HIGHLIGHTS
- who: Emmanuelle Duron from the Northwestern University, United States have published the research: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides A1-42 and Tau Proteins in Elderly Patients With Mild Cognitive Impairment, in the Journal: (JOURNAL)
- what: The aim of this study was to decipher the concentrations of SOM and NPY in elderly subjects with cognitive impairment and analyze these relationships with the other AD biomarkers. The BALTAZAR study aimed to study the relationships between plasmatic biomarkers (Aβ and soluble amyloid precursor protein α, sAPPα ) and determine the relevance of these biomarkers . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.